More about

Glioblastoma

News
November 09, 2019
4 min read
Save

Autologous antigen-loaded vaccine safe, feasible for neuroblastoma

NATIONAL HARBOR, Md. — An investigational vaccine of autologous dendritic cells loaded with autologous tumor antigens was safe and feasible as an adjuvant therapy when given after standard care therapies for glioblastoma, according to phase 2 trial results presented at the Society for Immunotherapy of Cancer Annual Meeting.

News
November 04, 2019
2 min read
Save

Plasma cell-free DNA may predict glioblastoma progression

Plasma cell-free DNA may predict glioblastoma progression

Plasma cell-free DNA appeared to be an effective biomarker for tumor burden and a viable prognostic tool for disease progression among newly-diagnosed patients with glioblastoma, according to results of a prospective study published in Clinical Cancer Research.

News
October 18, 2019
3 min read
Save

ID1 inhibition may improve efficacy of glioblastoma treatment

ID1 inhibition may improve efficacy of glioblastoma treatment

Investigators from St. Michael’s Hospital and The Hospital for Sick Children in Toronto have determined that the transcriptional regulatory protein ID1 appears to maintain cancer stem cells in glioblastoma.

News
October 11, 2019
2 min read
Save

Researchers identify potential therapeutic target for glioblastoma

Asparagine endopeptidase appeared to promote disease progression among patients with isocitrate dehydrogenase-wild-type glioblastoma by inactivation of p53, according to results of a prospective study published in Journal of the National Cancer Institute.

News
September 05, 2019
1 min read
Save

Nivolumab fails to extend PFS in glioblastoma subset

A randomized phase 3 trial designed to evaluate the addition of nivolumab to standard therapy for certain patients with newly diagnosed glioblastoma multiforme failed to meet one of its primary endpoints of PFS.

News
July 08, 2019
4 min read
Save

Despite ‘incremental’ progress, long-term survival rates ‘have not budged’ in glioblastoma

Despite ‘incremental’ progress, long-term survival rates ‘have not budged’ in glioblastoma

Although median and short-term OS rates have improved for glioblastoma, still only a small proportion of patients achieve 5-year survival, according to study results published in Mayo Clinic Proceedings.

News
June 01, 2022
9 min listen
Save

Healio Minute Podcast, Neurology Edition: Top Headlines - Week of May 30, 2022

Healio Minute Podcast, Neurology Edition: Top Headlines - Week of May 30, 2022

In this week’s edition, anxiety, depression worse among older men with vision impairment; emerging therapeutics may improve outcomes in pediatric patients with rare disorders; glioblastoma presents roadblock to successful immunotherapy; and more.

View more